Investigation on Use of Antiasthmatic Drugs in 192 Children with Asthmatic Bronchopneumonia

Huang Jinhua

您当前的位置：

首页 >

文章列表页 >

Investigation on Use of Antiasthmatic Drugs in 192 Children with Asthmatic Bronchopneumonia

更新时间：2022-11-03

- Investigation on Use of Antiasthmatic Drugs in 192 Children with Asthmatic Bronchopneumonia
- Vol. 26, Issue 8, Pages: 38-41(2020)
- 作者机构：
  
  柳州市妇幼保健院,广西,柳州,545001
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2020，
扫描看全文
Huang Jinhua. Investigation on Use of Antiasthmatic Drugs in 192 Children with Asthmatic Bronchopneumonia. [J]. 26(8):38-41(2020)
DOI：

Huang Jinhua. Investigation on Use of Antiasthmatic Drugs in 192 Children with Asthmatic Bronchopneumonia. [J]. 26(8):38-41(2020) DOI：

摘要

目的：了解某基层医院喘息性支气管肺炎住院患儿平喘用药情况。方法：回顾性分析某基层医院2017年8月至2017年12月收治的192例喘息性支气管肺炎患儿应用平喘药物治疗的情况。结果：婴幼儿是喘息性支气管肺炎主要患病人群，其中男性患儿占70.83%。平喘治疗以单独雾化吸入给药为主，其次为雾化吸入联合口服给药、雾化吸入联合静脉给药、雾化吸入联合口服给药和静脉给药三种给药方式进行平喘治疗。雾化吸入给药以吸入用布地奈德混悬液+吸入用沙丁胺醇溶液+吸入用异丙托溴铵溶液为主，占81.25%，吸入用布地奈德混悬液药品金额较高，占雾化吸入药物总费用的73.9%。结论：喘息性支气管肺炎住院患儿平喘治疗以雾化吸入给药为基础，个体化的平喘给药方案可保障患儿的用药安全。

Abstract

Objective: To investigate the use of antiasthmatic drugs in hospitalized children with asthmatic bronchopneumonia in a primary hospital. Methods: Retrospectively analysis was performed on clinical data of use of antiasthmatic drugs in 192 children with asthmatic bronchopneumonia admitted into a primary hospital from Aug. to Dec. of 2017. Results: Infants and young children were the main group of patients with asthmatic bronchopneumonia

among which males account for 70.83%. Antiasthmatic treatment was mainly given by aerosol inhalation alone

followed by aerosol inhalation combined with oral administration

aerosol inhalation combined with intravenous administration

aerosol inhalation combined oral administration and intravenous administration. Aerosol inhalation mainly consisted of budesonide suspension for inhalation + salbutamol solution for inhalation + ipratropium bromide for inhalation

accounting for 81.25%. The consumption sum of budesonide suspension for inhalation was higher

accounting for 73.9% of the total cost of nebulized inhalation drugs. Conclusion: The asthmatic bronchopneumonia treatment is based on nebulized inhalation therapy

antiasthmatic regimens should be individualized to ensure the safety of antiasthmatic treatment for children.

关键词

儿童喘息性支气管肺炎平喘药物合理用药

Keywords

childrenasthmatic bronchopneumoniaantiasthmatic drugsrational drug sue

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis of 36 Cases of Drug Poisoning in Children in a Grade III, Level A General Hospital andConsideration on Pharmaceutical Care

Application of Dexmedetomidine Combined with Hydromorphone Nasal Drip in Sedation of Mother-InfantSeparation before Adenoidectomy

Sirolimus in the Treatment of 5 Cases of Blue Rubber Bleb Nevus Syndrome in Children and Literature Review

Systematic Review on Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metabolic Disordersin Children

Drug Utilization Evaluation of Voriconazole for Injection in Children Based on Weighted Technique for Order Preference by Similarity to Ideal Solution Method

Related Author

Wang Peng

Xu Ying

Zhang Xiaoming

Zhang Shaonan

Li Changsong

Li Yunxiang

Li Xiaojing

Sun Canlin

Related Institution

The Second People’ s Hospital of Anhui Wuhu, Anhui Wuhu

Jiangsu Taizhou People’s Hospital, Jiangsu Taizhou

Children’s Hospital Affiliated to Zhengzhou University,Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou Key Laboratory of Children’s Digestive Diseases

Kunming Children’s Hospital / Children’s Hospital of Kunming Medical University, Kunming

Kunming MedicalUniversity, Kunming

⁰